Earnings

Tenax Therapeutics Q2 EPS $(0.35) Beats $(0.37) Estimate

Jul 31, 2026 · 07:30 AM ET· updated 3h ago

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.37) by 5.41 percent. This is a 29.63 percent decrease over losses of $(0.27) per share

Why It Matters

Tenax lost less money per share than experts predicted, which is good news for a company still losing money. When a losing company does better than expected, it shows the team might be getting closer to success.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

TENX14.82

-0.28 (-1.83%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.